Wills M L, Sauvageot J, Partin A W, Gurganus R, Epstein J I
Department of Pathology and The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Urology. 1998 May;51(5):759-64. doi: 10.1016/s0090-4295(98)00011-9.
There are few studies evaluating multiple variables on sextant biopsies with the intent to predict stage in radical prostatectomy specimens.
We studied 113 sextant biopsies with corresponding totally submitted radical prostatectomy specimens. Variables evaluated on sextant biopsies included total length and percent of cancer; maximum length and percent of cancer on one core; location (apex, mid, base); bilaterality; Gleason grade; number of cores involved; serum prostate-specific antigen (PSA) level; and serum PSA density (PSAD). Radical prostatectomy stage was classified as organ versus non-organ confined.
The following variables individually correlated with radical prostatectomy stage: total cancer measured in millimeters (P <0.0001) or percent (P <0.0005); biopsy Gleason score (P <0.0001); number of involved cores (P <0.0001); maximum cancer on one core measured in millimeters (P = 0.0001); maximum percent of cancer on one core (P = 0.01); bilaterality (P = 0.01); PSA level (P = 0.03), and PSAD (P = 0.001). The most predictive sets of two variables that correlated with stage included high Gleason score (P <0.0001) combined with numbers of cores involved (P = 0.002). When biopsies had Gleason scores of 6 or less, two or fewer positive cores, and serum PSA of 0 to 4 ng/mL, 89% were organ confined. When biopsies had Gleason scores of 6 or less with two unilaterally positive cores, 87% were organ confined. In biopsies with Gleason scores of 7 or more and more than one positive core, only 10% were organ confined.
The most important predictors of stage by sextant needle biopsy evaluation are numbers of cores involved with carcinoma and high Gleason score. Bilaterality and serum PSA values improved prediction in two small subgroups. In 37% of our population we were able to predict with a greater than 87% probability the organ-confined versus non-organ-confined status.
很少有研究评估前列腺六分区活检的多个变量,旨在预测根治性前列腺切除标本的分期。
我们研究了113例前列腺六分区活检病例及其对应的完整根治性前列腺切除标本。在六分区活检中评估的变量包括癌的总长度和百分比;单个组织条上癌的最大长度和百分比;位置(尖部、中部、基部);双侧性;Gleason分级;受累组织条数量;血清前列腺特异性抗原(PSA)水平;以及血清PSA密度(PSAD)。根治性前列腺切除的分期分为器官局限性与非器官局限性。
以下变量分别与根治性前列腺切除分期相关:以毫米计的癌总长度(P<0.0001)或百分比(P<0.0005);活检Gleason评分(P<0.0001);受累组织条数量(P<0.0001);单个组织条上以毫米计的癌最大长度(P = 0.0001);单个组织条上癌的最大百分比(P = 0.01);双侧性(P = 0.01);PSA水平(P = 0.03),以及PSAD(P = 0.001)。与分期相关的最具预测性的两个变量组合包括高Gleason评分(P<0.0001)与受累组织条数量(P = 0.002)。当活检Gleason评分为6或更低、阳性组织条为两个或更少且血清PSA为0至4 ng/mL时,89%为器官局限性。当活检Gleason评分为6或更低且有两个单侧阳性组织条时,87%为器官局限性。在Gleason评分为7或更高且阳性组织条多于一个的活检中,仅10%为器官局限性。
通过六分区穿刺活检评估分期的最重要预测因素是受累癌组织条数量和高Gleason评分。双侧性和血清PSA值在两个小亚组中改善了预测。在我们的研究人群中,37%的病例能够以大于87%的概率预测器官局限性与非器官局限性状态。